#Self-Expanding Surgical Stents Market size
Explore tagged Tumblr posts
Visit Tumblr Blog
Explore Tumblr blogs with no restrictions, modern design and the best experience.
Last Seen Tumblr Blogs
Fun Fact
Tumblr has been providing a Korean-language service since 2013.
Text
Biomaterials Market Opportunities, Statistics, COVID-19 Impact, and Forecast by 2032
Biomaterials, substances engineered to interact with biological systems, have become fundamental in various medical and scientific applications, including tissue engineering, drug delivery, wound healing, and regenerative medicine. Derived from both natural and synthetic sources, biomaterials can be tailored to enhance biocompatibility, structural integrity, and therapeutic effectiveness, making them crucial for patient care advancements. In medical applications, biomaterials are used in devices like pacemakers, heart valves, orthopedic implants, and wound care products, significantly improving patients’ quality of life. With the development of next-generation biomaterials, researchers aim to address the limitations of traditional materials, such as immune response and material degradation, while pushing the boundaries of medical innovation.
Over the years, the field of biomaterials has transformed from basic material design to include multifunctional and smart materials that actively respond to biological environments. The integration of nanotechnology, biotechnology, and 3D printing has enabled the development of biomaterials with enhanced properties, such as self-healing, targeted drug delivery, and regenerative capabilities. As a result, biomaterials are increasingly adopted in medical applications, particularly within orthopedic, cardiovascular, and dental fields, as they offer new ways to repair, restore, or replace damaged tissues and organs.
The Biomaterials Market Size was valued at USD 180 Billion in 2023 and is expected to reach USD 645.87 Billion by 2032 and grow at a CAGR of 16.10% over the forecast period 2024-2032.
Future Growth
The biomaterials market is anticipated to grow significantly in the coming years, driven by an aging population, rising prevalence of chronic diseases, and the ongoing demand for innovative treatment options. With advancements in fields such as nanotechnology and bioprinting, the scope of biomaterials is expanding, with new materials being developed to closely mimic human tissues. These breakthroughs are fueling growth in areas like regenerative medicine and personalized implants, allowing biomaterials to meet increasingly complex medical needs. Moreover, increasing investment in healthcare R&D and support from regulatory bodies for safer, high-quality biomaterials are expected to support the market’s upward trajectory.
Future growth is also expected to be supported by the expansion of biomaterials applications beyond conventional areas, such as drug delivery systems and bioactive coatings. With the advent of bioengineered tissues, the potential for biomaterials is being realized in complex therapies that require materials capable of adapting to a dynamic biological environment. Additionally, with the trend towards minimally invasive procedures and improved patient recovery times, biomaterials designed for surgical applications are gaining traction, broadening the scope of the market even further.
Key Players
Key players driving innovation in the biomaterials market include BASF SE, Johnson & Johnson, Zimmer Biomet, Medtronic PLC, Evonik Industries, Stryker Corporation, and DSM Biomedical. These companies are at the forefront of biomaterials development, leveraging advances in biotechnology and materials science to create safer, more effective solutions. Their efforts in R&D and strategic partnerships with healthcare providers, research institutions, and regulatory agencies have enabled them to develop a wide range of biomaterials that address diverse clinical needs, from cardiovascular stents to wound care products and orthopedic implants.
Drivers
Several factors are propelling the growth of the biomaterials market. One of the primary drivers is the rising incidence of chronic diseases such as cardiovascular disorders, orthopedic conditions, and diabetes, which require effective long-term solutions that biomaterials can provide. Biomaterials offer advantages over traditional materials by being adaptable to the body, reducing the risk of complications, and often promoting faster healing. This adaptability is particularly valuable in orthopedic and dental applications, where biomaterials can mimic the mechanical properties of natural tissues and support regeneration.
Another key driver is the rapid progress in biomaterials engineering, spurred by innovations in fields like nanotechnology, 3D printing, and biotechnology. These technologies enable precise design and modification of biomaterials, enhancing their compatibility with biological tissues and optimizing their performance in medical applications. Additionally, increased regulatory support for innovative biomaterial solutions, along with growing investments in healthcare infrastructure, particularly in emerging markets, is fueling market growth. As demand for less invasive and more effective treatments rises, biomaterials continue to evolve, meeting complex healthcare challenges with solutions that improve patient outcomes and reduce healthcare costs.
Key Takeaways
Biomaterials are critical for applications in tissue engineering, drug delivery, and regenerative medicine, contributing to improved patient care.
The biomaterials market is driven by technological advancements, including nanotechnology and 3D printing, which enhance biomaterials' capabilities and expand their applications.
Major players like Johnson & Johnson, BASF SE, and Medtronic are leading biomaterial innovation, focusing on creating safer, high-quality solutions for various clinical needs.
Increased prevalence of chronic diseases and the aging population are driving demand for biomaterials in medical applications such as orthopedic and cardiovascular care.
Supportive regulatory frameworks and rising R&D investments are accelerating the development and adoption of advanced biomaterials.
Get a Free Sample Copy of the Report: https://www.snsinsider.com/sample-request/3791
Conclusion
The biomaterials market is positioned for considerable growth as technological advancements and expanding clinical applications continue to shape its trajectory. With their potential to transform healthcare, biomaterials are becoming indispensable in providing effective solutions for chronic diseases, improving patient recovery times, and enabling regenerative medicine. As the need for biocompatible and multifunctional materials grows, biomaterials will play an increasingly vital role in the healthcare landscape, fostering innovation that meets the diverse needs of patients and medical professionals alike.
In a world that increasingly values minimally invasive and personalized treatment options, the biomaterials market is set to benefit from continuous R&D, supportive regulations, and strong market demand. By offering solutions that can seamlessly integrate with biological systems, biomaterials not only improve patient outcomes but also present sustainable and scalable options for addressing modern healthcare challenges.
0 notes
Text
Restoring Digestive Health: Insights into the Gastrointestinal Stent Market
The gastrointestinal system plays a pivotal role in our overall health and well-being, responsible for the digestion and absorption of nutrients essential for bodily functions. However, conditions such as gastrointestinal cancers, strictures, and obstructions can disrupt this delicate balance, leading to discomfort, pain, and complications. In such cases, gastrointestinal stents have emerged as vital medical devices, offering a minimally invasive solution to restore digestive health and alleviate symptoms. In this article, we explore the significance, trends, and impact of gastrointestinal stents in modern healthcare.
Gastrointestinal stents are specialized medical implants designed to open blocked or narrowed sections of the gastrointestinal tract, allowing for the passage of food, fluids, and bodily waste. These flexible, tubular devices are typically made from biocompatible materials such as nitinol, stainless steel, or silicone, and come in various shapes and sizes to accommodate different anatomical structures and conditions.
One of the primary applications of gastrointestinal stents is in the management of gastrointestinal cancers, including esophageal, gastric, and colorectal cancers. In patients with malignant strictures or obstructions, gastrointestinal stents provide immediate relief by restoring the patency of the affected area, relieving symptoms such as dysphagia, nausea, and vomiting, and improving quality of life. Moreover, stent placement can serve as a palliative measure to alleviate symptoms in patients with advanced or inoperable tumors, enabling them to eat and drink more comfortably and maintain nutritional intake.
Request the sample copy of report @ https://www.globalinsightservices.com/request-sample/GIS10289
In addition to cancer management, gastrointestinal stents are also used in the treatment of benign conditions such as strictures, fistulas, and leaks, as well as in the management of complications following gastrointestinal surgeries. In cases of benign strictures or strictures related to inflammatory bowel disease (IBD), stent placement can help alleviate symptoms and avoid the need for repeat surgeries. Similarly, in patients with gastrointestinal fistulas or leaks, stents can provide a temporary barrier to facilitate healing and prevent further complications.
Technological advancements and innovations in gastrointestinal stent design and delivery techniques have significantly improved patient outcomes and expanded the scope of gastrointestinal interventions. The development of self-expandable metal stents (SEMS) and covered stents, for example, has enhanced stent durability, flexibility, and biocompatibility, reducing the risk of migration, perforation, and tissue ingrowth. Moreover, the advent of endoscopic ultrasound (EUS)-guided stent placement and fluoroscopic-guided stent deployment has enabled precise positioning and improved procedural success rates, minimizing complications and optimizing clinical outcomes.
Furthermore, the growing prevalence of gastrointestinal disorders, the aging population, and the increasing adoption of minimally invasive endoscopic procedures have fueled demand for gastrointestinal stents worldwide. According to recent studies, the global gastrointestinal stent market is projected to experience steady growth in the coming years, driven by advancements in stent technology, increasing awareness among healthcare providers, and rising patient demand for less invasive treatment options.
In conclusion, gastrointestinal stents have revolutionized the management of a wide range of gastrointestinal conditions, offering patients a minimally invasive alternative to traditional surgical interventions. With ongoing technological advancements, expanding indications, and growing adoption in clinical practice, gastrointestinal stents are poised to play an increasingly important role in restoring digestive health and improving quality of life for patients worldwide. As healthcare providers continue to embrace innovation and evidence-based practices, the future of gastrointestinal stent therapy looks promising, with potential for further advancements in patient care and clinical outcomes.
0 notes
Text
Self Expanding Surgical Stents Market Size, Type, segmentation, growth and forecast 2023-2030
Self Expanding Surgical Stents Market
The Self Expanding Surgical Stents Market is expected to grow from USD 1.80 Billion in 2022 to USD 3.70 Billion by 2030, at a CAGR of 9.30% during the forecast period.
Get the Sample Report: https://www.reportprime.com/enquiry/sample-report/10072
Self Expanding Surgical Stents Market Size
Self-expanding surgical stents, as covered in a market research report, refer to medical devices used for the treatment of various conditions in hospitals, clinics, ambulatory surgical centers, and other healthcare settings. The market segment for these stents is categorized based on type, including metal stents, standard polymer stents, and biodegradable polymer stents. The report also covers market players such as Abbott, Medtronic, Boston Scientific, Stryker, STI Laser Industries, ELLA-CS, Laserage Technology, amg International GmbH, Meril, Elixir Medical, B. Braun Melsungen, Amaranth Medical, Arterial Remodeling Technologies, and Angiocare. The market region covered in the report include North America, Asia Pacific, Middle East, Africa, Australia, and Europe. The report highlights regulatory and legal factors specific to the market conditions, providing useful insights to potential buyers and stakeholders.
Self Expanding Surgical Stents Market Key Player
Abbott
Medtronic
Boston Scientific
Stryker
STI Laser Industries
Buy Now & Get Exclusive Discount on this https://www.reportprime.com/enquiry/request-discount/10072
Self Expanding Surgical Stents Market Segment Analysis
The global Self Expanding Surgical Stents market is expected to grow significantly in the forecast period due to the rising incidence of chronic diseases such as cardiovascular diseases and cancer. Self-expanding stents are used in a variety of procedures for treating narrowed or blocked vessels. They are also used in cancer treatment, gastroenterology, and urology. The market for self-expanding surgical stents is expected to witness considerable growth due to the increasing number of minimally invasive surgeries and technological advancements in stent design and materials.
One of the major factors driving the revenue growth of the Self Expanding Surgical Stents market is the increasing prevalence of cardiovascular diseases. According to the World Health Organization, cardiovascular diseases such as heart attack and stroke are the leading cause of death globally, accounting for 17.9 million deaths annually. Moreover, the adoption of minimally invasive surgeries and the increasing demand for advanced medical implants further boost the market growth.
The latest trends in the Self Expanding Surgical Stents market include the development of bioresorbable stents and the integration of nanotechnology in stent design. Bioresorbable stents are designed to dissolve over time, reducing the risk of complications associated with permanent metal stents. The integration of nanotechnology in stent design enhances the mechanical properties of stents and reduces the risk of restenosis.
However, the Self Expanding Surgical Stents market also faces some major challenges, including the high cost of surgical stents and the presence of alternative treatment options such as drug therapy and angioplasty. Moreover, the stringent regulatory requirements for stent approval and the lack of reimbursement in some regions pose a significant challenge for market growth.
The main findings of the report suggest that the global Self Expanding Surgical Stents market is poised for significant growth in the forecast period. Technological advancements in stent design and materials, coupled with the rising prevalence of chronic diseases, are expected to drive market growth. The report recommends that market players focus on innovation in stent design and materials and expand their market presence through strategic partnerships and collaborations.
Overall, the Self Expanding Surgical Stents market is expected to witness significant growth in the coming years due to the rising demand for minimally invasive surgeries and technological advancements in stent design and materials. However, market players need to overcome the challenges posed by regulatory requirements and alternative treatment options to realize their full potential.
This report covers impact on COVID-19 and Russia-Ukraine wars in detail.
Purchase This Report:https://www.reportprime.com/checkout?id=10072&price=3590
Market Segmentation (by Application):
Hospital
Clinics
Ambulatory Surgical Centers
Others
Information is sourced from www.reportprime.com
0 notes
Text
Global Nitinol Medical Devices Market Is Estimated To Witness High Growth Owing To Increasing Adoption of Minimally Invasive Surgeries
The global Nitinol Medical Devices market is estimated to be valued at US$36,417.2 million in 2021 and is expected to exhibit a CAGR of 10.3% over the forecast period, according to a new report published by Coherent Market Insights. A) Market Overview: Nitinol is a shape memory alloy that is widely used in the medical field for its unique properties. Nitinol medical devices possess the ability to return to their original shape after undergoing deformation, making them suitable for various applications such as stents, guidewires, orthopedic implants, and dental archwires. The key advantages of Nitinol medical devices include improved patient outcomes, reduced recovery time, and fewer complications compared to traditional surgical procedures. The increasing adoption of minimally invasive surgeries is driving the demand for Nitinol medical devices as they enable surgeons to perform procedures with smaller incisions, resulting in reduced scarring, pain, and recovery time for patients. B) Market Key Trends: One key trend in the Nitinol Medical Devices market is the growing adoption of Nitinol stents. Nitinol stents are widely used in the treatment of various cardiovascular diseases, such as coronary artery disease and peripheral artery disease. These stents are flexible and self-expanding, allowing for optimal vessel support and reducing the risk of restenosis. The superior properties of Nitinol, such as biocompatibility, excellent fatigue resistance, and shape memory capability, make it an ideal material for stent manufacturing. For instance, Boston Scientific Inc. offers SYNERGY™ Bioabsorbable Polymer Drug-Eluting Stent System made with Nitinol for the treatment of coronary artery disease. C) PEST Analysis: Political: The political landscape plays a crucial role in the growth of the Nitinol Medical Devices market. Government regulations and policies regarding medical device approvals and reimbursements can impact the market dynamics. Economic: The economic factors, such as healthcare expenditure, disposable income, and insurance coverage, influence the adoption of Nitinol medical devices. The growing healthcare infrastructure and increasing healthcare spending in emerging economies provide significant opportunities for market growth. Social: The rising prevalence of chronic diseases and the aging population are driving the demand for Nitinol medical devices. Additionally, the increasing awareness about advanced treatment options and the benefits of minimally invasive surgeries are further contributing to market growth. Technological: Technological advancements in Nitinol manufacturing processes and product design are enhancing the performance and efficacy of medical devices. For instance, EndoSmart GmbH offers innovative Nitinol-based surgical instruments that provide surgeons with enhanced precision and control during minimally invasive procedures. D) Key Takeaways: Market Size: The global Nitinol Medical Devices Market Growth is expected to witness high growth, exhibiting a CAGR of 10.3% over the forecast period, due to the increasing adoption of minimally invasive surgeries. Nitinol medical devices enable surgeons to perform procedures with smaller incisions, resulting in reduced scarring, pain, and recovery time for patients. Regional Analysis: North America is expected to dominate the Nitinol Medical Devices market due to the presence of a well-established healthcare infrastructure, favorable reimbursement policies, and high adoption of advanced medical technologies. However, the Asia-Pacific region is projected to witness the fastest growth during the forecast period. The growing geriatric population, increasing healthcare spending, and rising prevalence of chronic diseases in countries like China and India are driving the demand for Nitinol medical devices in this region. Key Players: Key players operating in the global Nitinol Medical Devices market include Zimmer Biomet, Merck KgaA, EndoSmart GmbH, Cook Medical, Boston Scientific Inc., B. Braun Melsungen AG, Arthrex Inc., W.L.
#Medical Devices#Healthcare Industry#Healthcare#Nitiniol Medical Devices#Nitiniol Medical Devices Market
0 notes
Text
QY Research Medical published a comprehensive research on Self-Expanding Surgical Stents Market, which provides a business strategies, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.
0 notes
Text
Nitinol Medical Devices Market Developments Status and Forecast 2027
Transparency Market Research (TMR) has published a new report titled, ‘Nitinol Medical Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the global Nitinol medical devices market was valued at US$ 14,571.7 Mn in 2018 and is projected to expand at a CAGR of 8.5% from 2019 to 2027.
Overview
· Nitinol is an unique class of shape-memory alloy that is made of nickel titanium. Nitinol properties include the shape-memory effect, super elasticity, and high damping capability. These technical properties of nitinol shape-memory alloy can be modified to a large extent by changes in composition, heat treatment, and mechanical working.
· Some of the major properties of nitinol include high fatigue strength, nonmagnetic, high power/weight ratio, corrosion resistance, heat resistance, and biocompatible.
Request A Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1685
· Nitinol is used in cardiovascular stents, kink resistant guide wires, minimally invasive surgical tools, and self-locking orthopedic devices. Recent advancements in nitinol includes developing new medical devices such as peripheral vascular stents, biodegradable polymer stents, and others.
· Based on product, the nitinol medical devices market is segmented into nitinol stents, nitinol guide wires, nitinol filters, nitinol basket, nitinol catheters, others (needles, staples, pins, sheath, and wires, etc.).
· North America dominated the global nitinol medical devices market in 2018 and the trend is anticipated to continue during the forecast period. Increasing adoption of technological advanced products and increasing prevalence of peripheral artery disease has contributed to dominant share of the region in global market.
· Asia Pacific is likely to be a highly lucrative market for nitinol medical devices and it is expected to expand at a high CAGR during the forecast period
Increased Clinical Application of Nitinol Based Products in Medical Procedures to Drive Market
· Usage of nitinol in the medical industry has increased due to demand for minimally invasive procedures utilizing novel instruments and implants. Medical applications range from orthodontic archwires and endoscopic instruments to endovascular stents which use nitinol as a base material for design and structure formation.
· According to the Pediatric Research, potential applications of shape-memory alloys is magnetostrictive and ferromagnetic shape memory alloys (FSMA) which are used to design pediatric cardiovascular devices. This is due to nitinol which changes shape in response to a change in temperature, and magnetostrictive or ferromagnetic properties.
· Thus, wide applications of nitinol based products in medical procedures is estimated to drive the growth of the market during the forecast period.
Nitinol Stents to Dominate Market
· In terms of product, the nitinol medical devices market is segmented into nitinol stents, nitinol guidewires, nitinol filters, nitinol basket, nitinol catheters, others (needles, staples, pins, sheath, and wires, etc.). Further nitinol guidewires is segmented into orthodontic guidewires and endoscopic guidewires.
· Nitinol stents accounted to larger market share in terms of revenue in 2016 and expected to grow in the forecast period due to increasing prevalence of cardiovascular diseases and peripheral vascular disease (PVD).
· According to the World Health Organization, cardiovascular diseases is a leading cause of deaths worldwide. More people die of cardiovascular diseases every year than any other cause. Each year, worldwide an estimated 17.9 million people dies due to cardiovascular diseases.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1685
Vascular segment to be Highly Lucrative Segment
· By application, the nitinol medical devices market is segmented into orthopedic, vascular, dental, gastroenterology, and others.
· Vascular segment accounted for larger market share in terms of revenue in 2018, vascular segmented accounted for more than 60% of the market share in 2018 due to increasing demand and adoption of nitinol based stents for vascular surgeries.
Hospitals Segment to offer attractive opportunity
· Based on the end-user, the market has been segmented into hospitals, clinics, ambulatory surgical centers and others.
· The hospitals segment dominated the market in 2018 and is anticipated to remain dominant in the forecast period owing to the increasing demand for minimal invasive surgeries and increasing number of surgeries for vascular and orthopedic diseases.
Request for Analysis of COVID-19 Impact on Nitinol Medical Devices Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1685
North America to Dominate Global Market
· In terms of region, the global nitinol medical devices market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
· North America dominated the global nitinol medical devices in 2018 and is estimated to maintain its leading position by the end of 2027 with sight decline in the market share.
· Increased adoption of technological advanced products in the region, high prevalence of cardiovascular disorders, rapidly aging population, and well established healthcare infrastructure etc. factors have contributed to dominant share of the region in global market.
· The market in the Asia Pacific region is projected to expand at exponential growth rate during the forecast period. The highest growth rate in the Asia Pacific region is attributed to increased market penetration of global players in highly populous countries such as China, India, Taiwan, rapidly improving healthcare industry in the region, and comparatively large patient pool with cardiovascular and gastrointestinal disorders.
Competitive Landscape
The global nitinol medical devices market is fragmented in terms of number of players. Key players operating in the global nitinol medical devices market includes, include B. Braun Melsungen AG, C. R. Bard, Inc., Arthrex, Inc., Zimmer Biomet Holdings, Inc., Cook Medical, Medtronic, W. L. Gore & Associates, Inc., Terumo Corporation, Abbott Laboratories, Boston Scientific Corporation and Endosmart GmbH.
About Us
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Rohit Bhisey Transparency Market Research Inc. CORPORATE HEADQUARTER DOWNTOWN, 1000 N. West Street, Suite 1200, Wilmington, Delaware 19801 USA Tel: +1-518-618-1030 USA �� Canada Toll Free: 866-552-3453 Website: https://www.transparencymarketresearch.com Blog: https://tmrblog.com Email: [email protected]
0 notes
Text
Endovascular Therapy Devices Market is expected to register a healthy CAGR during the forecast period.
Endovascular therapy Devices: Market Insights
A procedure involving endovascular therapy devices are used to insert a flexible, sterile plastic tube, stents or a catheter into a blood vessel to allow blood to be withdrawn from or medication to be delivered to a patient’s bloodstream over a period of time. These endovascular therapy devices can be used either for intravenous antibiotic treatment, chemotherapy, long-term intravenous feeding and blood transfusions. The market is challenged by many medical complexities requiring cardiovascular disease treatment from inside the blood vessel, strokes and other cardiovascular conditions. The market of endovascular therapy devices contains products which are less invasive, requiring patients to spend less time in the hospital, less recovery time and devices which cause less pain. The endovascular therapy devices market is dominated by minimally invasive, catheter-based procedure. These procedures are often performed in a cardiac catheterization labs present in hospitals.
Endovascular therapy Devices: Market Dynamics
The global endovascular therapy devices market will increase in forecast period 2018-28. Endovascular therapy devices market will be driven primarily by the rise in incidence of cardiovascular patients, economic power in some regions leading to lifestyle change, growing disposable income and, increasing expenditure. In addition, recent developments in stent technology and increased experience of interventionists will propel the growth of the global endovascular therapy devices market in the future. However, high cost involved in usage of new endovascular therapy devices, less awareness in economically poor nations, and US’s stringent tax regulation rules on medical devices are expected to be some of the major restraints in global market for endovascular therapy devices market.
Request Sample Report @https://www.futuremarketinsights.com/reports/sample/rep-gb-7693
Endovascular therapy Devices Market: Segmentation
Segmentation by Product Type:
Percutaneous endovascular aneurysm repair (EVAR)
Fenestrated EVAR
Aortic stents
Biodegradable Stents
Self-expanding Nitinol Stents
Thoracic aortic aneurysms grafts
Other Devices
Segmentation by Procedures:
Balloon Angioplasty
Angioplasty with Stent Placement
Drug-Eluting Stents (DES)
Renal Artery Angioplasty and Stenting
Carotid Artery Stenting
Transfemoral Carotid Artery Stenting
Transcarotid Artery Revascularization
Intravascular Brachytherapy
Atherectomy
Thrombolysis
Segmentation by Application
Pulmonary
Vascular
Cardiology
Surgery
Neurology
Radiology
Segmentation by End User Type:
Hospitals
Clinics
Research Institutes
Endovascular therapy Devices Market: Overview
The endovascular therapy devices market has grown exponentially since its inception in the early 1990s. Global estimates for the market reflects several factors. The use of manual compression has significantly lowered down in obese patients or patients on anticoagulation. However, complex procedures performed with a percutaneous endovascular therapy devices have taken strides as they offer bigger sheath sizes. As the economic landscape of health care becomes more competitive, endovascular therapy devices are becoming increasingly valuable because it frees up time for other work. Current market trends are focused on developing endovascular therapy devices that can be safe and efficient enough to close large-caliber femoral arteriotomies. As transcatheter aortic valve repair and percutaneous endovascular aneurysm repair are increasing in popularity, there will be tremendous opportunity for the manufacturers in the market to develop and manufacture simple but effective endovascular therapy devices in future..
Endovascular therapy Devices Market: Region-wise Outlook
Globally, global Endovascular therapy Devices market is segmented into seven key regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and Middle East. North America will account for the largest share in global Endovascular therapy Devices market. Besides the region’s Endovascular therapy Devices market growth will also increase due to obesity and diet, and new products lunch due to presence of leading manufacturers in the region. Europe with robust healthcare infrastructure, will drive the endovascular therapy devices market in this region. Technological advances in the region in the past decade have shifted revascularization strategies from traditional open surgical approaches. Focus has shifted towards lower-morbidity percutaneous endovascular treatments for patients with peripheral arterial disease. Asia Pacific mainly including India, China, AUS&NZ and Latin American countries are expected to be a significant market contributors in the rising Endovascular therapy Devices market. Advancements in stent designs by leading and local manufacturers in the region have fueled the growth of endovascular therapy devices in the region due liberalization of healthcare polices and trade related implications.
Request to View TOC @ https://www.futuremarketinsights.com/toc/rep-gb-7693
Endovascular therapy Devices Market: Key Players
Some of the key players present in global Endovascular therapy Devices market include Cardinal Health, Altura Medical, Lifetech Scientific BiFlow Medical, Boston Scientific, Endospan, Getinge, InspireMD, Japan Lifeline, Lombard Medical Technologies, Endologix, Medtronic, Nellix, Penumbra and Terumo. In addition presence of small and local manufacturers across the countries will account for competiveness in Endovascular therapy Devices market.
1 note
·
View note
Text
Airway Stent/Lung Stent Market is expected to reach $120 Million by 2024.
According to the new market research report " Lung Stent Market by Type (Tracheal, Bronchial, Laryngeal Stent), Product (Non-Expandable, Self-Expandable Stents), Material (Metal (Nitinol, Stainless Steel), Silicone, Hybrid), End User (Hospitals, ASCs) - Global Forecast to 2024", published by MarketsandMarkets™, the Airway Stent/Lung Stent Market is projected to reach USD 120 million by 2024 from USD 87 million in 2019, at a CAGR of 6.7%. Factors such as the rise in the prevalence of lung cancer & chronic respiratory diseases and the growing preference of minimally invasive procedures are expected to drive the growth of the airway/lung stent market. The need for customized lungs stents and the ability to currently print the stents using 3D printing techniques are expected to create growth opportunities for this market. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=32315890 The tracheobronchial stents segment is expected to account for the largest share of the Airway Stent/Lung Stent Market in 2019. Based on type, the Airway Stent/Lung Stent Market is categorized into tracheobronchial and laryngeal stents. In 2019, the tracheobronchial segment is expected to account for the largest share of the airway/lung stent market. The large share of this segment can be attributed to the high adoption of tracheal and bronchial stents in the treatment of lung cancer and other chronic respiratory diseases. By material, the metal stents segment is estimated to account for the largest share of the Airway Stent/Lung Stent Market in 2019. Based on the materials used to manufacture airway/lung stents, the market is segmented into metal, silicone, and hybrid stents. Certain advantages associated with metal stents, such as ease of insertion, thinner walls as compared to silicone lung stents, a lower risk of dislodgment or migration, and ability to adapt to the twisted airway are driving the growth of this segment. The self-expandable stents segment is estimated to hold the largest share of the Airway Stent/Lung Stent Market in 2019. Based on the product, the Airway Stent/Lung Stent Market is segmented into expandable and non-expandable stents. Of this, the expandable stents segment is estimated to hold a larger share of the market in 2019, due to the higher preference of these stents by surgeons due to advantages such as easy insertion in bronchoscopy procedures, lower risks of stent-induced complications, small size, and their easy removal. Hospitals will account for the largest share of the Airway Stent/Lung Stent Market in 2019. Based on end user, the Airway Stent/Lung Stent Market is segmented into hospitals and ambulatory surgical centers. In 2019, the hospitals segment will dominate the airway/lung stents market. The growing number of hospitals, increasing cases of lung cancer & other chronic airway diseases treated in hospitals, growth in the healthcare sector in emerging economies, and the increasing out-of-pocket healthcare expenditure across the globe are the key factors driving the demand for airway/lung stents in hospitals. Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=32315890 North America is expected to dominate the market in 2019 In 2019, North America is estimated to account for the largest share of the airway/lung stent market, followed by Europe. The dominant share of North America is attributed mainly to the presence of several large hospitals, robust healthcare infrastructure, rising prevalence of diseases, growing geriatric population, and the rising healthcare expenditure. The key players operating in the Airway Stent/Lung Stent Market include Boston Scientific Corporation (US), Taewoong Medical Co., Ltd. (South Korea), Micro-Tech (Nanjing) Co., Ltd. (China), Novatech SA (France), Boston Medical Products, Inc. (US), E. Benson Hood Laboratories, Inc. (US), Merit Medical Systems, Inc. (US), Cook Group (US), EFER ENDOSCOPY (France), ENDO-FLEX GmbH (Germany), Standard Sci. Tech Inc. (South Korea), and Stening SRL (Argentina), among
others.
0 notes
Text
Analysis of COVID-19 Crisis-driven Growth Opportunities in Intracranial Stents Market
Transparency Market Research (TMR) has published a new report titled ‘Intracranial Stents Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.’ According to the report, the global intracranial stents market was valued at US$ 298.7 Mn in 2017. It is projected to expand at a CAGR of 10.4% from 2018 to 2026. Aging population and longer life-expectancy, increased awareness, and acceptance of advanced devices are key factors that are likely to drive the intracranial stents market from 2018 to 2026.
Intracranial stents is a considerably less invasive technique, as compared to the conventional open surgery, for the management of vascular malformation. Hence, there are fewer complications and the hospital stay is relatively brief. Blood loss is lesser than traditional surgical treatment, and there is no obvious surgical incision. Intracranial stents can be used to treat tumors and vascular malformations that either cannot be removed surgically or would involve great risk if surgery was attempted. Intracranial stents is an effective and safe minimally-invasive alternative to surgery.
Request a PDF Sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=46416
The report offers detailed segmentation of the global intracranial stents market based on product type, disease indication, end-user, and region. In terms of product type, the self-expanding stents segment accounted for a dominant share of the market in 2017. High flexibility and low chances of restenosis has paved the way for the introduction of self-expanding stents and thereby, has fuelled the market. The introduction of advanced intracranial stents has revolutionized the intracranial stents market; factors such as reduction in infection risk, fast recovery are expected to drive the demand for intracranial stents during the forecast period.
Intracranial stenosis segment to account for major share
The intracranial stenosis segment is expected to account for a leading share of the market by the end of 2026. Rapid rise in the geriatric population, increase incidence of stroke, and technological innovation in neurology care devices are expected to drive the segment during the forecast period.
Request for Analysis of COVID19 Impact on Intracranial Stents Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=46416
Market in Asia Pacific to expand at a significant pace
North America held a major share of the global market, in terms of revenue, and is expected to maintain its position during the forecast period. North America is home to several key market players, such as Cook Medical, Johnson & Johnson Services, Inc., and Boston Scientific Corporation, that have their headquarters in the U.S., where they generate significant sales. Hence, North America is a leading market for intracranial stents. High awareness about latest health care technologies and higher purchasing power are anticipated to boost the intracranial stents market in North America. The intracranial stents market in Asia Pacific is expected to expand at a rapid pace, primarily due to improving health care infrastructure, rising disposable income, and technological advancements in countries such as China and India. Furthermore, rise in usage of minimally invasive devices for the treatment of various neurology disorders by surgeons, have boosted the demand for intracranial stents in Asia Pacific.
Buy now Intracranial Stents Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=46416<ype=S
Key players such as Boston Scientific Corporation, Penumbra, Inc. and Stryker Corporation to lead the market
The report also provides profiles of other major players operating in the global intracranial stents market. Other major players include Medtronic plc, Johnson & Johnson Services, Inc., Terumo Corporation, and Cook Medical.
More Trending Reports by Transparency Market Research:
https://www.prnewswire.com/news-releases/rapid-digitalization-rise-in-awareness-regarding-copd-treatments-to-drive-copd-drug-delivery-devices-market-says-tmr-301356815.html
https://www.prnewswire.com/news-releases/intravascular-ultrasound-ivus-devices-market-gains-from-rise-in-diagnosis-of-complex-cto-lesions-finds-tmr-301361488.html
https://www.prnewswire.com/news-releases/continuous-innovations-in-surgical-robotics-to-expand-outlook-of-minimally-invasive-surgery-market-global-market-valuation-to-exceed-us-23-6-bn-by-2031--notes-tmr-study-301367220.html
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR Syndicated Research report covers a different sector — such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.
Contact
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
0 notes
Text
Airway Stent/Lung Stent Market Worth $120 Million by 2024
According to the new market research report "Airway Stent/Lung Stent Market by Type (Tracheal, Bronchial, Laryngeal Stent), Product (Non-Expandable, Self-Expandable Stents), Material (Metal (Nitinol, Stainless Steel), Silicone, Hybrid), End User (Hospitals, ASCs) - Global Forecast to 2024", published by MarketsandMarkets™, the Airway Stent/Lung Stent Market is projected to reach USD 120 million by 2024 from USD 87 million in 2019, at a CAGR of 6.7%.
Browse in-depth TOC on "Airway Stent/Lung Stent Market"
137 – Tables
34 – Figures
164 – Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=32315890
Factors such as the rise in the prevalence of lung cancer & chronic respiratory diseases and the growing preference of minimally invasive procedures are expected to drive the growth of the airway/lung stent market. The need for customized lungs stents and the ability to currently print the stents using 3D printing techniques are expected to create growth opportunities for this market.
The tracheobronchial stents segment is expected to account for the largest share of the Airway Stent/Lung Stent Market in 2019.
Based on type, the Airway Stent/Lung Stent Market is categorized into tracheobronchial and laryngeal stents. In 2019, the tracheobronchial segment is expected to account for the largest share of the airway/lung stent market. The large share of this segment can be attributed to the high adoption of tracheal and bronchial stents in the treatment of lung cancer and other chronic respiratory diseases.
By material, the metal stents segment is estimated to account for the largest share of the Airway Stent/Lung Stent Market in 2019.
Based on the materials used to manufacture airway/lung stents, the market is segmented into metal, silicone, and hybrid stents. Certain advantages associated with metal stents, such as ease of insertion, thinner walls as compared to silicone lung stents, a lower risk of dislodgment or migration, and ability to adapt to the twisted airway are driving the growth of this segment.
The self-expandable stents segment is estimated to hold the largest share of the Airway Stent/Lung Stent Market in 2019.
Based on the product, the Airway Stent/Lung Stent Market is segmented into expandable and non-expandable stents. Of this, the expandable stents segment is estimated to hold a larger share of the market in 2019, due to the higher preference of these stents by surgeons due to advantages such as easy insertion in bronchoscopy procedures, lower risks of stent-induced complications, small size, and their easy removal.
Hospitals will account for the largest share of the Airway Stent/Lung Stent Market in 2019.
Based on end user, the Airway Stent/Lung Stent Market is segmented into hospitals and ambulatory surgical centers. In 2019, the hospitals segment will dominate the airway/lung stents market. The growing number of hospitals, increasing cases of lung cancer & other chronic airway diseases treated in hospitals, growth in the healthcare sector in emerging economies, and the increasing out-of-pocket healthcare expenditure across the globe are the key factors driving the demand for airway/lung stents in hospitals.
Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=32315890
North America is expected to dominate the market in 2019
In 2019, North America is estimated to account for the largest share of the airway/lung stent market, followed by Europe. The dominant share of North America is attributed mainly to the presence of several large hospitals, robust healthcare infrastructure, rising prevalence of diseases, growing geriatric population, and the rising healthcare expenditure.
The key players operating in the Airway Stent/Lung Stent Market include Boston Scientific Corporation (US), Taewoong Medical Co., Ltd. (South Korea), Micro-Tech (Nanjing) Co., Ltd. (China), Novatech SA (France), Boston Medical Products, Inc. (US), E. Benson Hood Laboratories, Inc. (US), Merit Medical Systems, Inc. (US), Cook Group (US), EFER ENDOSCOPY (France), ENDO-FLEX GmbH (Germany), Standard Sci. Tech Inc. (South Korea), and Stening SRL (Argentina), among others.
Browse Related Reports
Gastrointestinal / GI Stent Market by Type (Biliary, Esophageal, Colonic, Pancreatic Stent) Material (Nitinol, Stainless Steel, Plastic) Disease (Biliary Disease, GI Cancer, IBD), End User (Hospital, Ambulatory Surgery Center) - Global Forecast to 2022
Bioresorbable Scaffold/Bioabsorbable Stents Market by Material (Polymer/Metal), Absorption Rate (Slow, Fast), Application (Coronary Artery Disease/CAD, Peripheral/PAD) & End User (Hospital, Cardiovascular Center) - Global Forecasts to 2022
0 notes
Text
Non-vascular Stents Market Analysis, Segments, Top Key Players, Drivers and Trends by Forecast to 2025
9th July 2021 – The global Non-Vascular Stents Market size is expected to value at USD 1.4 billion by 2025. The market is subject to witness a substantial growth due to the increase in geriatric population, upsurge in incidences related to chronic disorders, and rise in healthcare expenditure by local governments. Furthermore, growing importance towards minimally invasive surgeries across the globe is expected to drive growth of the market in upcoming years.
Increasing incidences related to the gastrointestinal cancer across the globe, is further propelling demand for non-vascular stents. Increase in the number of patients diagnosed with cancer are significantly influencing growth of the market. Globally, the market is predicted to grow at CAGR of 5.1% in forecast period, providing numerous opportunity for market players to invest for research and development in the non-vascular stents industry. Geriatric population is more susceptible towards chronic diseases including lung cancer, pancreatic cancer, colorectal cancer, and other diseases such as stroke, asthma. Subsequently, increasing incidences related to chronic obstructive pulmonary disorders (COPD), chronic pancreatitis, prostate cancer, and glaucoma, are responsible for rising demand of non-vascular stents.
Access Non-vascular Stents Market Report with TOC @ https://www.millioninsights.com/industry-reports/non-vascular-stents-market
As per reports by World Health Organization (WHO), geriatric population is expected to reach two billion by 2050. Additionally, recent statistics presented by the American Cancer Society showcases as many as thirty thousand individuals suffering from stomach cancer in the North America region only. These factors are expected to fuel growth of the non-vascular stents market in coming years.
Rising adoption of the minimally invasive techniques such as nonvascular stenting is fueling the market growth of non-vascular stents. The minimally invasive techniques performed by tiny incisions instead of one large opening as they offer advantages such as quicker recovery times and less discomfort over traditional surgery. Additional advantages associated with adoption of minimally invasive techniques includes reduced pain during the surgery and minimum surgical scars. Reduction in the overall operational cost in comparison with traditional surgery techniques due to smaller incisions and minimum side effects, are propelling the demand of non-vascular stents industry.
The non-vascular stents market is majorly categorized into different market segments such as gastrointestinal stents segment, pulmonary, and urological stents segment. The gastrointestinal stents segment is considered as one of the fastest growing segment in the non-vascular stents industry with highest revenue generation in recent years. The gastrointestinal segment is further classified into different types such as biliary, pancreatic, and esophageal stents. Similarly, the pulmonary stents are also categorized into various types including silicone airway and metallic airway stents. Growing popularity of the urological stents segment is credited to the rise in occurrence of ureteral disorders such as renal calculi, kidney stone, urinary tract infections, and prostate cancer.
Non-vascular stents are commonly termed as a set of instruments that are specially designed for performing for a number of tasks involving biliary, bronchial and tracheal implantations. Rising application of the non-vascular stents is driving growth of the market. Non-vascular stents are utilized in order to improve prime patency in arteries and veins, which is commonly located at the site of stenotic. Non-vascular stents are classified into two common types such as balloon-expandable (BE) and self-expandable (SE).
The market is divided into regional market segment such as North America, Europe, Asia-Pacific, Latin America and Africa. North America and Europe have shown major growth in recent years owing to the rise adoption of latest methodologies for the treatment of chronic diseases and existence well-established healthcare infrastructure. Asia-Pacific region is predicted to hold major market share in the non-vascular stents market with massive growth in forecast period. Countries such as India, China and Singapore are leading the Asia-Pacific market with favorable government initiatives for use of such medical devices, rising geriatric population, and increasing healthcare expenditure.
The key players in the non-vascular stents industry are Medtronic Co., C. R. Bard Incoporations, Boston Scientific Co., Ella Co., Conmed Co., Hobbs Medical Incorporations, Cook Medical Co., Taewoong Medical Corporations, Synchron Med Incorporations, and Glaukos Co.
Request a Sample Copy of Non-vascular Stents Market Report @ https://www.millioninsights.com/industry-reports/non-vascular-stents-market/request-sample
0 notes
Text
Non-vascular Stents Market Growth Analysis, Trends Forecast by Regions and Types to 2025
9th July 2021 – The global Non-Vascular Stents Market size is expected to value at USD 1.4 billion by 2025. The market is subject to witness a substantial growth due to the increase in geriatric population, upsurge in incidences related to chronic disorders, and rise in healthcare expenditure by local governments. Furthermore, growing importance towards minimally invasive surgeries across the globe is expected to drive growth of the market in upcoming years.
Increasing incidences related to the gastrointestinal cancer across the globe, is further propelling demand for non-vascular stents. Increase in the number of patients diagnosed with cancer are significantly influencing growth of the market. Globally, the market is predicted to grow at CAGR of 5.1% in forecast period, providing numerous opportunity for market players to invest for research and development in the non-vascular stents industry. Geriatric population is more susceptible towards chronic diseases including lung cancer, pancreatic cancer, colorectal cancer, and other diseases such as stroke, asthma. Subsequently, increasing incidences related to chronic obstructive pulmonary disorders (COPD), chronic pancreatitis, prostate cancer, and glaucoma, are responsible for rising demand of non-vascular stents.
Access Non-vascular Stents Market Report with TOC @ https://www.millioninsights.com/industry-reports/non-vascular-stents-market
As per reports by World Health Organization (WHO), geriatric population is expected to reach two billion by 2050. Additionally, recent statistics presented by the American Cancer Society showcases as many as thirty thousand individuals suffering from stomach cancer in the North America region only. These factors are expected to fuel growth of the non-vascular stents market in coming years.
Rising adoption of the minimally invasive techniques such as nonvascular stenting is fueling the market growth of non-vascular stents. The minimally invasive techniques performed by tiny incisions instead of one large opening as they offer advantages such as quicker recovery times and less discomfort over traditional surgery. Additional advantages associated with adoption of minimally invasive techniques includes reduced pain during the surgery and minimum surgical scars. Reduction in the overall operational cost in comparison with traditional surgery techniques due to smaller incisions and minimum side effects, are propelling the demand of non-vascular stents industry.
The non-vascular stents market is majorly categorized into different market segments such as gastrointestinal stents segment, pulmonary, and urological stents segment. The gastrointestinal stents segment is considered as one of the fastest growing segment in the non-vascular stents industry with highest revenue generation in recent years. The gastrointestinal segment is further classified into different types such as biliary, pancreatic, and esophageal stents. Similarly, the pulmonary stents are also categorized into various types including silicone airway and metallic airway stents. Growing popularity of the urological stents segment is credited to the rise in occurrence of ureteral disorders such as renal calculi, kidney stone, urinary tract infections, and prostate cancer.
Non-vascular stents are commonly termed as a set of instruments that are specially designed for performing for a number of tasks involving biliary, bronchial and tracheal implantations. Rising application of the non-vascular stents is driving growth of the market. Non-vascular stents are utilized in order to improve prime patency in arteries and veins, which is commonly located at the site of stenotic. Non-vascular stents are classified into two common types such as balloon-expandable (BE) and self-expandable (SE).
The market is divided into regional market segment such as North America, Europe, Asia-Pacific, Latin America and Africa. North America and Europe have shown major growth in recent years owing to the rise adoption of latest methodologies for the treatment of chronic diseases and existence well-established healthcare infrastructure. Asia-Pacific region is predicted to hold major market share in the non-vascular stents market with massive growth in forecast period. Countries such as India, China and Singapore are leading the Asia-Pacific market with favorable government initiatives for use of such medical devices, rising geriatric population, and increasing healthcare expenditure.
The key players in the non-vascular stents industry are Medtronic Co., C. R. Bard Incoporations, Boston Scientific Co., Ella Co., Conmed Co., Hobbs Medical Incorporations, Cook Medical Co., Taewoong Medical Corporations, Synchron Med Incorporations, and Glaukos Co.
Request a Sample Copy of Non-vascular Stents Market Report @ https://www.millioninsights.com/industry-reports/non-vascular-stents-market/request-sample
0 notes
Text
Tracheobronchial Stents Market Growth (Status and Outlook) 2020-2027
Market Analysis and Insights: Tracheobronchial Stents Market
Tracheobronchial Stents Market By Type (Self-Expandable Stents, Non-Expandable Stents, Balloon-Expandable Stents), Material (Metal Stents, Silicone Stents, Hybrid Stents), Application (Hospitals, Ambulatory Surgery Centers), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E, Egypt, Israel, Rest of Middle East & Africa), Market Trends and Forecast to 2027.
Tracheobronchial stents market is expected to reach a market value of USD 145.61 million while growing at a CAGR of 6.65% in the forecast period of 2020-2027. Increasing occurrence of lung cancer and respiratory diseases among growing population has been directly impacting the growth of tracheobronchial stents market.
Avail sample copy of report before purchase @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-tracheobronchial-stents-market
Stent is a type of tube made up of metal as well as plastic which is inserted into a lumen of an anatomic vessel to keep the passage away open. Tracheobronchial stents are usually placed bronchoscopically and laryngoscopically that helps in the treatment of various chronic lung diseases.
Increasing life expectancy and geriatric population, growing preferences of minimally invasive procedures, surging healthcare expenditure for the provision of better technology are some of the factors that will accelerate the growth of the tracheobronchial stents market in the forecast period of 2020-2027. On the other hand, increasing need for the provision of customised lung stents along with 3D printing and increasing demand of biodegradable and lung eluting lung stents will further create new opportunities for the growth of the tracheobronchial stents market during the above mentioned forecast period.
Increasing complications associated with stents and availability of substitutes and decreasing preferences of tobacco smoking are acts as a market restraint for tracheobronchial stents market in the above mentioned forecast period.
This global tracheobronchial stents market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research tracheobronchial stents market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-tracheobronchial-stents-market
Global Tracheobronchial Stents Market Scope and Market Size
Tracheobronchial stents market is segmented on the basis of type, material and application. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
Based on type, tracheobronchial stents market is segmented into self-expandable stents, non-expandable stents and balloon-expandable stents.
Tracheobronchial stents market has also been segmented on the basis of application into hospitals and ambulatory surgery centers.
Based on material, tracheobronchial stents market is segmented into metal stents, silicone stents and hybrid stents. Metal stents have been further segmented into nitinol stents, stainless steel stents and others.
Tracheobronchial Stents Market Country Level Analysis
Tracheobronchial stents market is analysed and market size insights and trends are provided by country, type, material and application as referenced above.
The countries covered in the tracheobronchial stents market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the tracheobronchial stents market due to improved healthcare infrastructure, growing geriatric population and increasing occurrence of diseases.
The country section of the tracheobronchial stents market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Directly buy full report from here @ https://www.databridgemarketresearch.com/checkout/buy/singleuser/global-tracheobronchial-stents-
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
Tracheobronchial stents market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for tracheobronchial stents market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the tracheobronchial stents market. The data is available for historic period 2010 to 2018.
Competitive Landscape and Tracheobronchial Stents Market Share Analysis
Tracheobronchial stents market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to tracheobronchial stents market.
The major players covered in the tracheobronchial stents market report are Boston Scientific Corporation, Merit Medical Systems, BD, TAEWOONG, Micro-Tech (Nanjing) Co., Ltd., Cook, Novatech SA, M.I.TECH., EFER ENDOSCOPY, Fuji Systems Corp., HOOD LABORATORIES, Meditek Systems Pvt. Ltd., Kapitex Healthcare Ltd., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available: Global Tracheobronchial Stents Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.
Read other Trending Report of Data Bridge Market Research
Asia-Pacific Flexible Digital Video Cystoscopes Market
Asia-Pacific Intraoperative Imaging Market
Asia-Pacific Skin Tightening Market
Dental Diagnostic & Surgical Equipment Market
Europe Cardiac Pacemakers Market
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact: Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
0 notes
Text
Coronary Stent Market Size Report Analysis, Trends, Size, Competitive Landscape 2027
Synopsis of the Global Coronary Stent Market
Coronary stents are small stretchy tube-like devices used to expand the arteries of the patient in order to prevent blockage. A coronary stent is inserted into the artery of a patient suffering from a coronary disease due to the build-up of plaque. It is used for widening the narrowed arteries, and it helps in reducing chest pain and the chance of heart attack
The global coronary stent market is mainly driven by the high prevalence of heart-related diseases and huge demand for diagnosis and treatment methods. Additionally, the increasing availability of diagnostic services for coronary heart diseases also fuels the growth of the market. Moreover, favorable reimbursement policies are likely to boost the market growth.
also read @ https://www.marketwatch.com/press-release/coronary-stent-global-market-industry-analysis-growth-trends-opportunity-and-forecast-2018-to-2023-2021-01-17
Coronary Stent Market Overview
Coronary stents are a small tube-like device that is placed into the coronary arteries of a patient in order to keep the arteries open in the coronary heart disease treatment and prevent the same from any kind of blockage. It is used for broadening the narrowed arteries and helps curb-down chest pain and the chances of heart attack. According to the recently published report by the team of Market Research Future (MRFR), the global coronary stent market is projected to grow at a rate of 7.8% during the review period.
The market is identified to be driven by a number of factors, including the wide-spread prevalence of heart-related diseases and a proliferating demand for diagnosis and treatment methods. Additionally, the growing availability of diagnostic services for coronary heart diseases is also pushing the growth of the market. A growing percentage of positive outcomes with stenting and the emergence of a number of advancing technologies in the coronary artery field is adding to the market growth of the device. It is also worth noting that alternative treatment methods for curing coronary artery diseases and a number of product recall cases are likely to hinder the market growth of coronary stents.
Coronary Stent Market Segmentation
Global coronary stent market segmentation is classified on the basis of mode of delivery, type, material, and end-user.
By type, the market segments into drug-eluting stents, bioabsorbable stents, and bare-metal stents.
By material, the market comprises cobalt chromium, metallic stents, stainless steels, platinum chromium, nickel titanium, and others.
By end-user, the market includes hospitals and clinics, ambulatory surgical centers, cardiac centers, and others.
By mode of delivery, the market divides into self-expanding and balloon-expandable stents.
Coronary Stent Market Regional Analysis
segments into North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa.
North America is the dominant region of the lot and is primarily driven by the surging patient population suffering from coronary heart diseases, an increasing pool of geriatric population, and growing investments in the healthcare sector. Latin America, on the other hand, is slated to be one of the fastest growing regional market owing to the rising demand for coronary heart disease treatment options and the availability of technologically advanced devices for diagnosis purposes.
With Germany and the UK being the major contributors, the European coronary stent market is expected to flourish in the forthcoming years. An increasing emphasis on the diagnosis and treatment of heart and other related diseases has majorly driven the market in this region. The increasing healthcare expenditure is another key contributor to the market’s growth.
Asia-Pacific stands out as the fastest growing market amongst all the mentioned regions. This projection can be primarily attributed to the increasing prevalence of cardiovascular diseases and a rising focus on performing early diagnosis and treatment of heart diseases. The Middle East & African region is forecasted to exhibit a slow and steady rise in the growth ladder. The regional market is starting to show positive signs with an increasing number of healthcare facilities offering treatments for chronic diseases and an increasing growth of the medical device sector, especially for diagnostic devices. In Africa, increasing awareness concerning coronary heart diseases is pushing the market growth herein.
Coronary Stent Market Competitive Landscape
Coronary Stent Market Sizeincludes some highly noteworthy players including B. Braun Melsungen AG (Germany), MicroPort Scientific Corporation (China), Vascular Concepts (India), Terumo Corporation (Japan), BIOTRONIK SE & Co. KG (Germany), Translumina GmbH (Germany), Biosensors International Group, Ltd. (Singapore), Meril Life Sciences Pvt. Ltd. (India), Elixir Medical Corporation (U.S.), Boston Scientific Corporation (U.S.), STENTYS SA (France), Medtronic plc (Ireland), Abbott Laboratories (U.S.), Reva Medical Inc. (U.S.), and others.
Coronary Stent Industry Overview
Feb 8th, 2019, CeloNova BioSciences, Inc. (CeloNova), an innovative global medical device leader, announced the signing of a three-year group purchasing agreement with HealthTrust for their new game-changing Coronary Stent named COBRA PzF(TM) NanoCoated Coronary Stent (NCS) System.
Feb 22nd, 2019, Biotronic announced the approval of Osiro, an ultrathin-strut coronary stent, from the US Food and Drug Administration for the treatment of coronary artery disease. It was approved in Europe eight years back and has been implanted upon millions of patients globally.
Get More Information on Coronary Stent Market Research Report – Forecast to 2023 @
https://www.marketresearchfuture.com/reports/coronary-stent-market-5915
RELATED REPORTS
Global Invisible Orthodontics Market Research Report—Forecast till 2025
Global Pain Patch Market Research Report—Forecast till 2025
Body Composition Analyzers Market Research Report - Global Forecast till 2025
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services
0 notes
Text
Report Predicts Non-vascular Stents Market to Reach USD 1.4 billion by 2025
The global Non-Vascular Stents Market size is expected to value at USD 1.4 billion by 2025. The market is subject to witness a substantial growth due to the increase in geriatric population, upsurge in incidences related to chronic disorders, and rise in healthcare expenditure by local governments. Furthermore, growing importance towards minimally invasive surgeries across the globe is expected to drive growth of the market in upcoming years.
Increasing incidences related to the gastrointestinal cancer across the globe, is further propelling demand for non-vascular stents. Increase in the number of patients diagnosed with cancer are significantly influencing growth of the market. Globally, the market is predicted to grow at CAGR of 5.1% in forecast period, providing numerous opportunity for market players to invest for research and development in the non-vascular stents industry.
Geriatric population is more susceptible towards chronic diseases including lung cancer, pancreatic cancer, colorectal cancer, and other diseases such as stroke, asthma. Subsequently, increasing incidences related to chronic obstructive pulmonary disorders (COPD), chronic pancreatitis, prostate cancer, and glaucoma, are responsible for rising demand of non-vascular stents.
As per reports by World Health Organization (WHO), geriatric population is expected to reach two billion by 2050. Additionally, recent statistics presented by the American Cancer Society showcases as many as thirty thousand individuals suffering from stomach cancer in the North America region only. These factors are expected to fuel growth of the non-vascular stents market in coming years.
Rising adoption of the minimally invasive techniques such as nonvascular stenting is fueling the market growth of non-vascular stents. The minimally invasive techniques performed by tiny incisions instead of one large opening as they offer advantages such as quicker recovery times and less discomfort over traditional surgery. Additional advantages associated with adoption of minimally invasive techniques includes reduced pain during the surgery and minimum surgical scars. Reduction in the overall operational cost in comparison with traditional surgery techniques due to smaller incisions and minimum side effects, are propelling the demand of non-vascular stents industry.
Avail Sample Report @ https://www.millioninsights.com/industry-reports/non-vascular-stents-market/request-sample
The non-vascular stents market is majorly categorized into different market segments such as gastrointestinal stents segment, pulmonary, and urological stents segment. The gastrointestinal stents segment is considered as one of the fastest growing segment in the non-vascular stents industry with highest revenue generation in recent years. The gastrointestinal segment is further classified into different types such as biliary, pancreatic, and esophageal stents. Similarly, the pulmonary stents are also categorized into various types including silicone airway and metallic airway stents. Growing popularity of the urological stents segment is credited to the rise in occurrence of ureteral disorders such as renal calculi, kidney stone, urinary tract infections, and prostate cancer.
Non-vascular stents are commonly termed as a set of instruments that are specially designed for performing for a number of tasks involving biliary, bronchial and tracheal implantations. Rising application of the non-vascular stents is driving growth of the market. Non-vascular stents are utilized in order to improve prime patency in arteries and veins, which is commonly located at the site of stenotic. Non-vascular stents are classified into two common types such as balloon-expandable (BE) and self-expandable (SE).
The market is divided into regional market segment such as North America, Europe, Asia-Pacific, Latin America and Africa. North America and Europe have shown major growth in recent years owing to the rise adoption of latest methodologies for the treatment of chronic diseases and existence well-established healthcare infrastructure. Asia-Pacific region is predicted to hold major market share in the non-vascular stents market with massive growth in forecast period. Countries such as India, China and Singapore are leading the Asia-Pacific market with favorable government initiatives for use of such medical devices, rising geriatric population, and increasing healthcare expenditure.
The key players in the non-vascular stents industry are Medtronic Co., C. R. Bard Incoporations, Boston Scientific Co., Ella Co., Conmed Co., Hobbs Medical Incorporations, Cook Medical Co., Taewoong Medical Corporations, Synchron Med Incorporations, and Glaukos Co.
Read Complete Report WithTOC @ https://www.millioninsights.com/industry-reports/non-vascular-stents-market
Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email:[email protected]
0 notes
Text
Gastrointestinal Stents Market , Demand, Size, Share, Scope & Forecast To 2027
Reports and Data has published a report on the Global Gastrointestinal Stents Market. It includes a database of all market essentials, with key facts and figures represented in the form of tables, pie charts, graphs, etc., giving the reader a better understanding of the market. Currently, the Gastrointestinal Stents market is witnessing industry-wide development. The research study presents a detailed analysis of the industry and projects the future market growth by examining the current growth factors, opinions of industry experts, and other industry-related information derived from reliable sources. The report offers estimates for Global Gastrointestinal Stents Market Forecast till 2027.
To Buy This Report, Click Here @ https://www.reportsanddata.com/report-detail/gastrointestinal-stents-market The report includes descriptive profiles of major companies, which consists of the legal names, headquarters, website, market standing, historical development, and top 5 closest competitors derived by inspecting their gross revenue, along with contact information. Every company’s growth rate, gross revenue, and profit margin have also been discussed in the study. It also assesses other expansion tactics implemented by leading companies including mergers, acquisitions, and product launches.
Extensive profiles of over ten leading manufacturers and over ten retailers have also been included in the report, along with a historical assessment of the market for the years 2021 and 2027, highlighting the recent development observed in the market. The report discusses the key micro- and macro-economic influences that were present in the market in 2021. The assessment includes accurate market insights into potential market opportunities and roadblocks in the industry. The report assimilates statistical data derived from authentic sources in the industry, facilitated by expert opinions.
Key players operating in the gastrointestinal stent market are Boston Scientific, Cook Medical, ELLA-CS, Olympus America, ConMed, Gore Medical, TaeWoong Medical, Hobbs Medical, C.R. Bard and Merit Medical Endotek.
Product Outlook (Revenue, USD Million, 2017 - 2027)
Biliary Stent
Duodenal Stent
Colonic Stent
Pancreatic Stent
Esophageal Stent
Material Outlook (Revenue, USD Million, 2017 - 2027)
Self-expanding Metal Stents
Plastic Stents
Application Outlook (Revenue, USD Million, 2017 - 2027)
Biliary Disease
Colorectal Cancer
Stomach Cancer
Others
End-Use Outlook (Revenue, USD Million, 2017 - 2027)
Hospitals
Ambulatory surgical centers
Specialized Clinics
Scope of the Report:
The all-encompassing research weighs up on various aspects including but not limited to important industry definition, product applications, and product types. The pro-active approach towards analysis of investment feasibility, significant return on investment, supply chain management, import and export status, consumption volume and end-use offers more value to the overall statistics on the Gastrointestinal Stents market. All factors that help business owners identify the next leg for growth are presented through self-explanatory resources such as charts, tables, and graphic images.
Grab Your Report at an Impressive Discount! Please Click Here @ https://www.reportsanddata.com/discount-enquiry-form/3561
Key selling points of this research study
1. The study gives an in-depth evaluation of the evolving competitive scenario that gives the reader/client a competitive edge.
2. It offers a holistic view of all critical aspects boosting or limiting the growth of the sector
3. The market intelligence report derives an eight-year forecast, including historical, contemporary, and potential market prospects, projecting the estimated progress of the market.
4. It aids informed decision-making by offering an exhaustive database of the pivotal market segments and sub-segments.
Fill in your details to get your hands on an Exclusive Sample of this Report @ https://www.reportsanddata.com/sample-enquiry-form/3561
Reports And Data, Gastrointestinal Stents Market, Gastrointestinal Stents Market size, Gastrointestinal Stents Market share, Gastrointestinal Stents Market trends, Gastrointestinal Stents Market forecast, Gastrointestinal Stents Market analysis, Gastrointestinal Stents Market scope, Gastrointestinal Stents Market manufacturer, Gastrointestinal Stents Market vendors, Gastrointestinal Stents Market players, Gastrointestinal Stents Market top player, Gastrointestinal Stents Market key player, Gastrointestinal Stents Market prominent player, Gastrointestinal Stents Market major manufacturers, Gastrointestinal Stents Market report
0 notes